These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28837209)

  • 21. Thrombus age, clinical presentation, and reperfusion grade in myocardial infarction.
    Carol A; Bernet M; Curós A; Rodríguez-Leor O; Serra J; Fernández-Nofrerías E; Mauri J; Bayes-Genís A
    Cardiovasc Pathol; 2014; 23(3):126-30. PubMed ID: 24582379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of a High Ratio of Soluble to Membrane-Bound LOX-1 in Aspirated Coronary Thrombi From Patients With ST-Segment-Elevation Myocardial Infarction.
    Lee AS; Wang YC; Chang SS; Lo PH; Chang CM; Lu J; Burns AR; Chen CH; Kakino A; Sawamura T; Chang KC
    J Am Heart Assoc; 2020 Jan; 9(2):e014008. PubMed ID: 31928155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissimilarity of increased phosphatidylserine-positive microparticles and associated coagulation activation in acute coronary syndromes.
    Liu Y; He Z; Zhang Y; Dong Z; Bi Y; Kou J; Zhou J; Shi J
    Coron Artery Dis; 2016 Aug; 27(5):365-75. PubMed ID: 27058313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI.
    Saia F; Komukai K; Capodanno D; Sirbu V; Musumeci G; Boccuzzi G; Tarantini G; Fineschi M; Tumminello G; Bernelli C; Niccoli G; Coccato M; Bordoni B; Bezerra H; Biondi-Zoccai G; Virmani R; Guagliumi G;
    JACC Cardiovasc Imaging; 2015 May; 8(5):566-575. PubMed ID: 25890582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Wang Z; Liu N; Ren L; Lei L; Ye H; Peng J
    Arq Bras Cardiol; 2018 Apr; 110(4):333-338. PubMed ID: 29538502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
    Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Older coronary thrombus is an independent predictor of 1-year mortality in acute myocardial infarction.
    Li X; Kramer MC; Damman P; van der Wal AC; Grundeken MJ; van Straalen JP; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Fischer JC; Tijssen JG; de Winter RJ
    Eur J Clin Invest; 2016 Jun; 46(6):501-10. PubMed ID: 26988709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction.
    Park HJ; Noh JH; Eun JW; Koh YS; Seo SM; Park WS; Lee JY; Chang K; Seung KB; Kim PJ; Nam SW
    Oncotarget; 2015 May; 6(15):12970-83. PubMed ID: 26025919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.
    Piccolo R; Franzone A; Koskinas KC; Räber L; Pilgrim T; Valgimigli M; Stortecky S; Rat-Wirtzler J; Silber S; Serruys PW; Jüni P; Heg D; Windecker S
    Am J Cardiol; 2016 Aug; 118(3):345-52. PubMed ID: 27289296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events.
    Gao J; Yan KT; Wang JX; Dou J; Wang J; Ren M; Ma J; Zhang X; Liu Y
    Sci Rep; 2020 Feb; 10(1):2639. PubMed ID: 32060329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Sebben JC; Pinto Ribeiro DR; Lopes RD; de Winter R; Harskamp R; Cambruzzi E; Schmidt MM; Martinelli ES; Gottschall CA; Quadros AS
    Am Heart J; 2016 Feb; 172():26-33. PubMed ID: 26856212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    He PC; Duan CY; Liu YH; Wei XB; Lin SG
    BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction.
    Natsukawa T; Maeda N; Fukuda S; Yamaoka M; Fujishima Y; Nagao H; Sato F; Nishizawa H; Sawano H; Hayashi Y; Funahashi T; Kai T; Shimomura I
    J Atheroscler Thromb; 2017 Aug; 24(8):793-803. PubMed ID: 28100880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010.
    Gottlieb S; Kolker S; Shlomo N; Matetzky S; Leitersdorf E; Segev A; Goldenberg I; Tzivoni D; Weisz G; Moriel M
    Int J Cardiol; 2016 May; 210():133-8. PubMed ID: 26945433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.
    Desch S; Stiermaier T; de Waha S; Lurz P; Gutberlet M; Sandri M; Mangner N; Boudriot E; Woinke M; Erbs S; Schuler G; Fuernau G; Eitel I; Thiele H
    JACC Cardiovasc Interv; 2016 Jan; 9(2):113-22. PubMed ID: 26793952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.